Senior Global Access Evidence Leader - HTA Statistician

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come.

Join Roche, where every voice matters.

Our Global Pharma Strategy (GPS) team plays a pivotal role in shaping the future of healthcare by driving the strategic direction of our innovative product portfolio. As a member of the GPS team, you will be at the forefront of transforming groundbreaking scientific discoveries into accessible and impactful healthcare solutions for patients worldwide. We are seeking a dynamic and visionary senior professional who thrives in a collaborative environment and is passionate about making a difference.

We are seeking a dynamic and visionary Senior Global Access Evidence Leader with deep EU HTA and advanced statistical and evidence-synthesis expertise to join our Evidence Chapter—a professional recognized within the European HTA community for advancing evidence standards and shaping submissions that secure patient access across EU member states. In this role, you will thrive in a collaborative environment and be passionate about making a difference.

• Lead EU HTA evidence strategy:
  Shape Roche's approach to EU HTA submissions by embedding sophisticated, anticipatory evidence strategies into clinical development from inception, ensuring alignment with EMA regulations, and the new EU HTA regulations. Position us as a benchmark for evidence excellence across European markets
• Drive methodological innovation in EU contexts:
  Leverage your established networks within European HTA bodies, payers, and health authorities to advance evidence standards and best practices—influencing how the industry approaches submissions to national HTA organizations and contributing to the evolution of EU HTA frameworks
• Architect compelling EU submissions:
  Design innovative, region‑specific evidence packages that anticipate the needs of EMA committees, HTA bodies and national payers. Identify strategic evidence gaps early, pioneer novel data sources and analyses, and translate complex statistical findings into narratives that drive reimbursement and access decisions across EU markets
• Establish Roche as an EU HTA expert:
  Leverage your reputation and deep relationships within the European Access/HTA ecosystem to elevate submission quality, engage proactively with key opinion leaders and HTA bodies, and position Roche as a thought leader in EU evidence generation and submission strategy
• Lead strategic statistical analysis for EU evidence packages:
  Lead and critically evaluate complex statistical analyses—including network meta‑analyses and real‑world evidence syntheses—ensuring methodological rigor and compliance with EU HTA requirements while translating findings into compelling, region‑appropriate narratives
• Enable affiliates and cross‑functional teams:
  Guide European affiliate teams and cross‑functional partners in building robust EU submission strategies, ensure alignment across EMA development pathways and national HTA submissions, and mentor colleagues on evolving EU regulatory and HTA landscapes
• Contribute to EU HTA evolution:
  Maintain influential engagement with European HTA bodies, regulatory agencies, and academic networks—actively participating in professional forums, contributing to methodological debates, and ensuring Roche remains at the forefront of EU evidence standards and innovation

• Advanced expertise &…